1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,177 | 0,226 | 03.03. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | hVIVO acquires biological material storage specialist Cryostore | 2 | Sharecast | ||
| Do | hVIVO PLC - Acquisition of Cryostore for up to £3.2m | 2 | RNS | ||
| 17.02. | IN BRIEF: hVIVO signs £2 million deal as aims to progress hMPV care | 3 | Alliance News | ||
| 17.02. | Hvivo signs £2m contract with new biopharma client | 2 | Sharecast | ||
| 17.02. | hVIVO PLC - £2m hMPV characterisation study contract | 1 | RNS | ||
| 05.02. | hVIVO reports positive results from Shionogi RSV trial | 7 | Sharecast | ||
| 05.02. | Shionogi's RSV antiviral shows promise in hVIVO trial | 4 | Investing.com | ||
| HVIVO Aktie jetzt für 0€ handeln | |||||
| 05.02. | hVIVO PLC - Shionogi reports positive RSV trial results | 4 | RNS | ||
| 03.02. | hVIVO wins contract for RSV drug human trial for Inhalon Biopharma | 5 | Alliance News | ||
| 03.02. | hVIVO signs human challenge trial contract with Inhalon Biopharma | 2 | Sharecast | ||
| 03.02. | hVIVO PLC - RSV contract signed with Inhalon Biopharma | 1 | RNS | ||
| 29.01. | hVIVO eyes double-digit revenue rise, announces new acquisition | 1 | Alliance News | ||
| 29.01. | Hvivo acquires two clinical research units, FY revenues up 11.9pc | 3 | Sharecast | ||
| 29.01. | hVIVO expands with German units acquisition for €10m | 4 | Investing.com | ||
| 29.01. | hVIVO PLC - Acquisition: two Clinical Research Units from CRS | 1 | RNS | ||
| 29.01. | hVIVO PLC - Trading update | 1 | RNS | ||
| 27.01. | hVIVO (LON:HVO) Shares Up 10% - Still a Buy? | 2 | MarketBeat | ||
| 27.01. | hVIVO (LON:HVO) Trading 10% Higher - Still a Buy? | 3 | MarketBeat | ||
| 27.01. | hVIVO (LON:HVO) Stock Price Up 10% - Time to Buy? | 2 | MarketBeat | ||
| 27.01. | ILiAD Biotechnologies, LLC: ILiAD and hVIVO Sign LOI for Pivotal Phase 3 Trial of BPZE1 Pertussis Vaccine Following FDA Meeting | 216 | Business Wire | Trial anticipated for H2 2025 to evaluate most advanced next generation intranasal pertussis vaccine for whooping cough
ILiAD Biotechnologies, LLC, a biotech company developing BPZE1, the most... ► Artikel lesen |
Seite:
1 2 3 Weiter >>
45 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PLUS THERAPEUTICS | 1,074 | -4,96 % | Plus Therapeutics Inc.: Plus Therapeutics Advances Lead Drug Rhenium (186Re) Obisbemeda for Patients with Leptomeningeal Metastases | AUSTIN, Texas, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the "Company" or "Plus Therapeutics"), a clinical-stage pharmaceutical company developing targeted radiotherapeutics... ► Artikel lesen | |
| SPINEWAY | 0,094 | -2,89 % | Spineway marks its return to Arab Health 2025 with new distribution agreements | ||
| LIFEWARD | 1,640 | 0,00 % | Lifeward Ltd.: Lifeward to Report Fourth Quarter and Fiscal Year-End 2024 Financial Results on March 7, 2025 | ||
| JD HEALTH | 4,300 | -0,46 % | JD Health-Aktie gewinnt 2,79 Prozent (4,18 €) | Im Plus liegt derzeit die Aktie von JD Health . Das Papier kostete zuletzt 4,18 Euro. Ein Preisanstieg in Höhe von 12 Cent erfreut derzeit die Aktionäre von JD Health. Der Preis für die Aktie liegt... ► Artikel lesen | |
| EKSO BIONICS | 0,498 | +7,56 % | EKSO BIONICS HOLDINGS, INC. Q4 Sales Increase | ||
| IMUNON | 0,765 | -7,27 % | Imunon, Inc.: IMUNON Reports 2024 Financial Results and Provides Business Update Highlighting Significant Progress Towards the Initiation of a Pivotal Phase 3 Study | IMNN-001 remains the first immunotherapy to achieve a meaningful overall survival benefit in advanced ovarian cancer Patient enrollment in Phase 3 pivotal trial of IMNN-001 scheduled to begin in... ► Artikel lesen | |
| ROCKWELL MEDICAL | 1,565 | +2,49 % | ROUNDUP/Aktien New York: Erneute Dow-Verluste - Nasdaq-Rally pausiert | NEW YORK (dpa-AFX) - An den US-Börsen bahnt sich am Dienstag für den Dow Jones Industrial der neunte Schwächetag in Folge an. Anders als zuletzt wird der US-Leitindex dabei aber von den anderen US-Indizes... ► Artikel lesen | |
| AVINGER | 0,340 | -6,08 % | Avinger, Inc.: Avinger Reports Third Quarter 2024 Results | Lower Operating Cost Profile Drives Improved Productivity, Increased Gross Margin REDWOOD CITY, CA / ACCESSWIRE / November 7, 2024 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company... ► Artikel lesen | |
| VIRIDIAN THERAPEUTICS | 14,000 | +1,45 % | Viridian Therapeutics, Inc.\DE - S-8, Securities to be offered to employees in employee benefit plans | ||
| SINTX TECHNOLOGIES | 2,980 | 0,00 % | Why SINTX Technologies Stock Is Down 21% | ||
| AETHLON MEDICAL | 0,540 | 0,00 % | XFRA DIVERSE INSTRUMENTE: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILCASTOR MARITIME... ► Artikel lesen | |
| STAGEZERO LIFE SCIENCES | 0,028 | -100,00 % | Stagezero Life Sciences Ltd (2): Stagezero loses $1.43-million (U.S.) in nine months | ||
| NEURONETICS | 4,035 | -0,37 % | Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | ||
| ARCH THERAPEUTICS | - | - | Arch Therapeutics, Inc. - 8-K, Current Report | ||
| SAVARIA | 12,000 | +4,35 % | Dividendenbekanntmachungen (28.02.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACNB CORPORATION US0008681092 0,32 USD 0,3078 EUR ADVANCED DRAINAGE SYSTEMS INC US00790R1041 0,16 USD 0,1539 EUR AGNC INVESTMENT... ► Artikel lesen |
Das Unternehmen HVIVO PLC kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell +4,82 % bei einem Aktienkurs von 0,174 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu HVIVO PLC finden Sie auf Wallstreet Online.
